You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 17, 2024

CLINICAL TRIALS PROFILE FOR TROFINETIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for trofinetide

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02715115 ↗	A Safety Study of NNZ-2566 in Pediatric Rett Syndrome	Completed	rettsyndrome.org	Phase 2	2016-03-01	The purpose of this study is to determine whether NNZ-2566 is safe and well tolerated in the treatment of Rett syndrome in children and adolescents.
NCT02715115 ↗	A Safety Study of NNZ-2566 in Pediatric Rett Syndrome	Completed	Neuren Pharmaceuticals Limited	Phase 2	2016-03-01	The purpose of this study is to determine whether NNZ-2566 is safe and well tolerated in the treatment of Rett syndrome in children and adolescents.
NCT04181723 ↗	Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)	Active, not recruiting	ACADIA Pharmaceuticals Inc.	Phase 3	2019-11-06	To investigate the efficacy of treatment with oral trofinetide versus placebo in females with Rett syndrome
NCT04279314 ↗	Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome	Enrolling by invitation	ACADIA Pharmaceuticals Inc.	Phase 3	2020-01-29	To investigate the safety and tolerability of long-term treatment with oral trofinetide in girls and women with Rett syndrome
NCT04776746 ↗	Open-Label Extension Study of Trofinetide for Rett Syndrome	Enrolling by invitation	ACADIA Pharmaceuticals Inc.	Phase 3	2020-11-08	To investigate the safety and tolerability of continued long-term treatment with oral trofinetide in girls and women with Rett syndrome
NCT04988867 ↗	An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome	Recruiting	ACADIA Pharmaceuticals Inc.	Phase 2/Phase 3	2021-09-22	To investigate the safety and tolerability of long-term treatment with oral trofinetide in girls with Rett syndrome
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for trofinetide

Condition Name

Chart
Table

Condition Name for trofinetide
Intervention	Trials
Rett Syndrome	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for trofinetide
Intervention	Trials
Syndrome	5
Rett Syndrome	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for trofinetide

Trials by Country

Map
Table

Trials by Country for trofinetide
Location	Trials
United States	62
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for trofinetide
Location	Trials
Minnesota	5
Alabama	5
Massachusetts	5
Texas	4
Pennsylvania	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for trofinetide

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for trofinetide
Clinical Trial Phase	Trials
Phase 3	3
Phase 2/Phase 3	1
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for trofinetide
Clinical Trial Phase	Trials
Enrolling by invitation	2
Completed	1
Recruiting	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for trofinetide

Sponsor Name

Chart
Table

Sponsor Name for trofinetide
Sponsor	Trials
ACADIA Pharmaceuticals Inc.	4
rettsyndrome.org	1
Neuren Pharmaceuticals Limited	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for trofinetide
Sponsor	Trials
Industry	5
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.